Cargando…

C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy

BACKGROUND: As an indispensable marker of complement cascades activation, C4d was confirmed of its crucial role in the pathogenesis of both lupus nephritis (LN) and IgA nephropathy (IgAN). While the studies directly comparing the diagnostic value, and outcomes predicting function of C4d between LN a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaoqian, Yuan, Yanhong, Shao, Xinghua, Pang, Huihua, Che, Xiajing, Cao, Liou, Zhang, Minfang, Xu, Yao, Ni, Zhaohui, Qi, Chaojun, Wang, Qin, Mou, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841560/
https://www.ncbi.nlm.nih.gov/pubmed/35174193
http://dx.doi.org/10.3389/fmed.2022.832998
_version_ 1784650862153433088
author Yang, Xiaoqian
Yuan, Yanhong
Shao, Xinghua
Pang, Huihua
Che, Xiajing
Cao, Liou
Zhang, Minfang
Xu, Yao
Ni, Zhaohui
Qi, Chaojun
Wang, Qin
Mou, Shan
author_facet Yang, Xiaoqian
Yuan, Yanhong
Shao, Xinghua
Pang, Huihua
Che, Xiajing
Cao, Liou
Zhang, Minfang
Xu, Yao
Ni, Zhaohui
Qi, Chaojun
Wang, Qin
Mou, Shan
author_sort Yang, Xiaoqian
collection PubMed
description BACKGROUND: As an indispensable marker of complement cascades activation, C4d was confirmed of its crucial role in the pathogenesis of both lupus nephritis (LN) and IgA nephropathy (IgAN). While the studies directly comparing the diagnostic value, and outcomes predicting function of C4d between LN and IgAN are still absent. METHODS: A cohort of 120 LN patients, 120 IgAN patients who were diagnosed by renal biopsy between January 2015 and December 2017 and 24 healthy age matched controls were prospectively analyzed. The patients were followed till December 2020. The outcomes were adverse disease treatment response (disease relapse) and kidney disease progression event (decline of estimated glomerular filtration rate by more than 20% or end-stage kidney disease). The renal C4d deposition proportion and pattern were compared between IgAN and LN patients. In addition, the relationship between renal C4d deposition and disease subtypes, disease relapse as well as disease progression for LN and IgAN patients were also analyzed. RESULTS: The LN, IgAN patients and healthy controls were well matched in ages. The follow-up period was 38.5 (30.3–60.8) months for LN patients and 45.0 (30.5–57.0) months for IgAN patients. 78 patients (65.0%) with LN had renal C4d deposition, compared with only 39 IgAN patients (32.5%) with C4d deposition in renal tissues (P < 0.001). The LN patients shared different renal C4d distribution patterns with IgAN patients. Compared with IgAN patients, the C4d deposition in LN patients was significantly more in renal glomerulus (P < 0.001) and less in renal tubules (P = 0.003). For disease subtypes, renal C4d deposition was especially strong in class V membranous LN and IgAN with tubulointerstitial fibrosis (T1/T2) lesions. Renal C4d deposition was independently correlated with the disease relapse of LN patients (HR = 1.007, P = 0.040), and acted as an independent predictor of disease progression during the follow-up period for IgAN patients (HR = 1.821, P = 0.040). CONCLUSIONS: Renal C4d distribution proportion and pattern differed between LN and IgAN patients. The presence of C4d in renal tissue acted as an independent predictor of relapse for LN patients and disease progression for IgAN patients.
format Online
Article
Text
id pubmed-8841560
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88415602022-02-15 C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy Yang, Xiaoqian Yuan, Yanhong Shao, Xinghua Pang, Huihua Che, Xiajing Cao, Liou Zhang, Minfang Xu, Yao Ni, Zhaohui Qi, Chaojun Wang, Qin Mou, Shan Front Med (Lausanne) Medicine BACKGROUND: As an indispensable marker of complement cascades activation, C4d was confirmed of its crucial role in the pathogenesis of both lupus nephritis (LN) and IgA nephropathy (IgAN). While the studies directly comparing the diagnostic value, and outcomes predicting function of C4d between LN and IgAN are still absent. METHODS: A cohort of 120 LN patients, 120 IgAN patients who were diagnosed by renal biopsy between January 2015 and December 2017 and 24 healthy age matched controls were prospectively analyzed. The patients were followed till December 2020. The outcomes were adverse disease treatment response (disease relapse) and kidney disease progression event (decline of estimated glomerular filtration rate by more than 20% or end-stage kidney disease). The renal C4d deposition proportion and pattern were compared between IgAN and LN patients. In addition, the relationship between renal C4d deposition and disease subtypes, disease relapse as well as disease progression for LN and IgAN patients were also analyzed. RESULTS: The LN, IgAN patients and healthy controls were well matched in ages. The follow-up period was 38.5 (30.3–60.8) months for LN patients and 45.0 (30.5–57.0) months for IgAN patients. 78 patients (65.0%) with LN had renal C4d deposition, compared with only 39 IgAN patients (32.5%) with C4d deposition in renal tissues (P < 0.001). The LN patients shared different renal C4d distribution patterns with IgAN patients. Compared with IgAN patients, the C4d deposition in LN patients was significantly more in renal glomerulus (P < 0.001) and less in renal tubules (P = 0.003). For disease subtypes, renal C4d deposition was especially strong in class V membranous LN and IgAN with tubulointerstitial fibrosis (T1/T2) lesions. Renal C4d deposition was independently correlated with the disease relapse of LN patients (HR = 1.007, P = 0.040), and acted as an independent predictor of disease progression during the follow-up period for IgAN patients (HR = 1.821, P = 0.040). CONCLUSIONS: Renal C4d distribution proportion and pattern differed between LN and IgAN patients. The presence of C4d in renal tissue acted as an independent predictor of relapse for LN patients and disease progression for IgAN patients. Frontiers Media S.A. 2022-01-31 /pmc/articles/PMC8841560/ /pubmed/35174193 http://dx.doi.org/10.3389/fmed.2022.832998 Text en Copyright © 2022 Yang, Yuan, Shao, Pang, Che, Cao, Zhang, Xu, Ni, Qi, Wang and Mou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yang, Xiaoqian
Yuan, Yanhong
Shao, Xinghua
Pang, Huihua
Che, Xiajing
Cao, Liou
Zhang, Minfang
Xu, Yao
Ni, Zhaohui
Qi, Chaojun
Wang, Qin
Mou, Shan
C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
title C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
title_full C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
title_fullStr C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
title_full_unstemmed C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
title_short C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
title_sort c4d as a screening tool and an independent predictor of clinical outcomes in lupus nephritis and iga nephropathy
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841560/
https://www.ncbi.nlm.nih.gov/pubmed/35174193
http://dx.doi.org/10.3389/fmed.2022.832998
work_keys_str_mv AT yangxiaoqian c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT yuanyanhong c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT shaoxinghua c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT panghuihua c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT chexiajing c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT caoliou c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT zhangminfang c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT xuyao c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT nizhaohui c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT qichaojun c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT wangqin c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy
AT moushan c4dasascreeningtoolandanindependentpredictorofclinicaloutcomesinlupusnephritisandiganephropathy